Rochester Medical Corporation to Participate in the 24th Annual
Piper Jaffray Healthcare Conference
STEWARTVILLE, Minn.,
Nov. 15, 2012 /PRNewswire/ --
Rochester Medical Corporation (NASDAQ:ROCM) today announced its
upcoming participation in the 24th Annual Piper Jaffray
Healthcare Conference on Tuesday, November
27, 2012, at The New York Palace Hotel, New York. Anthony J.
Conway, President and Chief Executive Officer, and
David A. Jonas, Chief Financial
Officer, are scheduled to present at 2:00 pm
Eastern Time.
A live webcast will be accessible through a link provided on the
Investor Relations homepage of Rochester Medical's website,
www.rocm.com. Mr. Conway and Mr. Jonas will also host one-on-one
meetings with investors.
Forward-Looking Statements
This press release contains "forward-looking statements" with
the meaning of the Private Securities Litigation Reform Act of
1995. Such statements include, but are not limited to,
statements about the future financial and operating results of
Rochester Medical. Such statements are based on currently
available information, operating plans and management's
expectations about future events and trends. Such statements
inherently involve significant risks and uncertainties that could
cause actual results to differ materially from those predicted in
such forward-looking statements, including the uncertainty of
estimated revenues and profits, the uncertainty of current domestic
and international economic conditions that could adversely affect
the level of demand for the Company's products and increased
volatility in foreign exchange rates, the uncertainty of market
acceptance of new product introductions, and our level of
success in increasing Rochester Medical Direct Sales revenue, the
uncertainty of gaining new strategic relationships or locating and
capitalizing on strategic opportunities, the uncertainty of timing
of Private Label Sales revenues (particularly international
customers), FDA and other regulatory review and response times, and
other risk factors listed from time to time in the Company's SEC
reports and filings, including, without limitation, the section
entitled "Risk Factors" in the Company's Annual Report on Form 10-K
for the year ended September 30,
2011, and quarterly reports on Forms 10-Q. Readers are
cautioned not to place undue reliance on any such forward-looking
statements, which speak only as of the date they are made.
The Company undertakes no obligation to update any forward-looking
statements, whether as a result of new information, future events
or otherwise.
About Rochester Medical Corporation
Rochester Medical Corporation develops, manufactures, and
markets disposable medical catheters and devices for urological and
continence care applications. The Company also sells certain
ostomy and wound and scar care products and other brands of
urological products into the European marketplace.
For further information, please contact Anthony J. Conway, President and Chief Executive
Officer or David A. Jonas, Chief
Financial Officer of Rochester Medical Corporation at (507)
533-9600 or Parice Halbert, CFA, at
Westwicke Partners (443) 213-0500. More information about
Rochester Medical is available on its website at
http://www.rocm.com.
SOURCE Rochester Medical Corporation